EUVIMEDEUVIMED entdecken
Open Access

Prognostic significance of dynamic minimal residual disease trajectories in newly diagnosed multiple myeloma

Jiapei Yu, Qi Chen, Min Shi, Lu Liu, Yuanyuan Jin iD, Xuxing Shen iD, Tian Tian, Yujie Wu, Lijuan Chen iD

British Journal of Haematology · 2026-09 · 209 (3) · 1101-1110

DOI: 10.1111/bjh.70704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 21.07.2026. Verfasst von Jiapei Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Specialized Diseases Clinical Research Fund of Jiangsu Province Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While minimal residual disease (MRD) is a well‐recognized prognostic marker in multiple myeloma (MM), the clinical significance of dynamic MRD trajectories and MRD‐driven therapies remains incompletely elucidated. This retrospective study analysed serial MRD results from 231 newly diagnosed multiple myeloma (NDMM) patients who achieved ≥ complete remission (CR). MRD negativity independently predicted superior progression‐free survival (PFS) (hazard ratio [HR] = 0.222; 95% confidence interval [CI] 0.124–0.400, p < 0.001) and overall survival (OS) (HR = 0.280; 95% CI 0.097–0.809, p = 0.019). Sustaining MRD negativity for ≥6 months improved OS ( p < 0.001), while negativity duration ≥12 months conferred dual prognostic benefits for both PFS and OS (both p < 0.001). Patients with late MRD conversion (after ≥12 months of negativity) had OS comparable to those with sustained negativity ( p = 0.339). Elevated circulating plasma cell at diagnosis (HR = 3.761; 95% CI 1.225–11.550, p = 0.021), failure to achieve MRD negativity post‐induction (HR = 2.886; 95% CI 1.065–7.819, p = 0.037), and a high abnormal PC/BMPC% at MRD conversion (HR = 4.091; 95% CI 1.429–11.701, p = 0.009) were independent risk factors for progression post‐conversion. These findings demonstrate the prognostic significance of sustained MRD negativity and support serial MRD monitoring as a potential basis for individualized MRD‐driven treatment strategies in NDMM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansNeoplasm, ResidualPrognosisRetrospective StudiesFemaleMaleMiddle AgedAgedAdultRemission InductionAged, 80 and over

Stichwörter der Autor:innen

dynamic changesminimal residual diseasemultiple myelomaprognosis

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

ORCID-Profile: Yuanyuan Jin, Xuxing Shen, Lijuan Chen

Förderung

  • National Natural Science Foundation of China
  • Specialized Diseases Clinical Research Fund of Jiangsu Province Hospital

Zitieren

APA

Yu, J., Chen, Q., Shi, M., Liu, L., Jin, Y., Shen, X., Tian, T., Wu, Y., & Chen, L. (2026). Prognostic significance of dynamic minimal residual disease trajectories in newly diagnosed multiple myeloma. British Journal of Haematology, 209(3), 1101-1110. https://doi.org/10.1111/bjh.70704

Vancouver

Yu J, Chen Q, Shi M, Liu L, Jin Y, Shen X, et al. Prognostic significance of dynamic minimal residual disease trajectories in newly diagnosed multiple myeloma. British Journal of Haematology. 2026;209(3):1101-1110. doi:10.1111/bjh.70704

BibTeX
@article{Yu2026,
  author = {Yu, Jiapei and Chen, Qi and Shi, Min and Liu, Lu and Jin, Yuanyuan and Shen, Xuxing and Tian, Tian and Wu, Yujie and Chen, Lijuan},
  title = {Prognostic significance of dynamic minimal residual disease trajectories in newly diagnosed multiple myeloma},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {3},
  pages = {1101--1110},
  doi = {10.1111/bjh.70704}
}
Kostenlos starten →